NCT06728943 Efficacy of Intra-Ureteric Aminophylline Installation After Failed Stone Accessibility by Semi-rigid Ureteroscopy. Prospective Trial
| NCT ID | NCT06728943 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Al-Azhar University |
| Condition | Ureterocopic Lithotripsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-12-01 |
| Primary Completion | 2028-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2024-12-01 with a primary completion date of 2028-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study we will test the effect of local intraureteric aminophylline instillation through Ureteric stent and Reaching stone without the need of ballon dilataion
Eligibility Criteria
Inclusion Criteria: * The study will include patients with failed stone accessibility by semi-rigid ureteroscopy. Exclusion Criteria: * Child age group * Pre stented patients * Contraindications to aminophylline (hypersensitivity to drug components, pregnancy or lactation ,…) * Contraindications to ureteroscopy (active urinary tract infection - Contraindications to general or spinal anesthesia - Uncorrected bleeding disorders)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06728943 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Ureterocopic Lithotripsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06728943 currently recruiting?
Yes, NCT06728943 is actively recruiting participants. Contact the research team at prof_mohamed_fawzy@yahoo.com for enrollment information.
Where is the NCT06728943 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06728943 clinical trial?
NCT06728943 is sponsored by Al-Azhar University. The trial plans to enroll 300 participants.